Dr. Smita Shenoy
Professor
Reg.No:69671
Department of Pharmacology
Qualification: MBBS, MD (Karnataka Medical Council registration number: 69671)
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
She:
o Trains undergraduate and post graduate students
o Guides undergraduates, postgraduates and PhD scholars
o Is a member of internal quality assurance cell, career guidance cell and pharmacovigilance?committee
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Pharmacology | 2nd year MBBS |
| Pharmacology MD: PGY1, PGY2 and PGY3 | 1st-3rd year MD |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| MD | Pharmacology | Kasturba Medical College, 亚洲通_亚洲通官网 | 2003 |
| MBBS | North Bengal Medical College, Sushrutanagar | 1993 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| KMC,亚洲通_亚洲通官网 | Professor | Administrative, training and guiding UGs, PGs and PhD research scholars, conduct research | 01.12.2019- Till date |
| KMC,亚洲通_亚洲通官网 | Professor and Head | Administrative, training and guiding UGs, PGs and PhD research scholars, conduct research | 01.12.2019- 30.11.2024 |
| KMC, 亚洲通_亚洲通官网 | Associate Professor | Administrative, training and guiding UGs and PGs, conduct research | 04.03.2009-30.11.2019 |
| KMC, 亚洲通_亚洲通官网 | Assistant Professor | Training and guiding UGs and PGs, conduct research | 04.03.2004-03.03.2009 |
| KMC, 亚洲通_亚洲通官网 | Tutor | Training UGs, conduct research | 01.01.2001-31.12.2003 |
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Basic and clinical pharmacology
Area of Expertise
Neuropharmacology, Traditional medicines, HIV, toxicity studies
Area of 亚洲通_亚洲通官网
Neurodevelopmental toxicity, traditional medicines in hepatic diseases and psoriasis, drug-drug interactions, adverse drug reactions
Professional Affiliations & Contributions
- Member of Indian Pharmacological Society
- Member of Institutional Ethics Committee, KMC & KH (2016 – 2018)
- Coordinator, Quality cell, KMC 亚洲通_亚洲通官网, Oct 2017 – Feb 2019.
- Member Secretary, Institutional Animal Ethics Committee, KMC 亚洲通_亚洲通官网 , 2017-2022
- Study coordinator for clinical trials???
Books
o? ?Pharmacology for Medical graduates: (Elsevier) 5th?edition 2022
????????????? ???????????????Tara Shanbhag, Smita Shenoy
o? ?Pharmacology for Nurses: (Elsevier) 3rd ?edition 2023
?????????????? ??????????????Tara Shanbhag, Smita Shenoy, Veena Nayak
Chapter
o?? Lal SM, Kamath A, Parida A, Shenoy S.??Nanopharmacokinetics assessment. In: Thorat ND, Kumar N, eds.??Nano-pharmacokinetics and theranostics. 1st?ed. London: Academic Press (imprint of Elsevier); 2021.p.171-92.??
1. Kumar S., Shenoy S, Swamy RS, Ravichandiran V, Kumar N. Fluoride-Induced Mitochondrial Dysfunction and Approaches for Its Intervention. Biological Trace Element 亚洲通_亚洲通官网 2024; 202(3): 835–49.
2. Abhijna Ballal R , Shivakumar Reddy K , Divya Chandran , Sumukha Hegde , Raghavendra Upadhya , Praveen Kumar SE , Smita Shenoy , Vasudha Devi and Dinesh Upadhya. Cell-specific extracellular vesicle-encapsulated exogenous GABA controls seizures in epilepsy. Stem Cell 亚洲通_亚洲通官网 & Therapy. Dec 2024; 15(1):108.
3. Ashwija Kolakemar, Shivaprakash Gangachannaiah, Sadhana N Holla, Mohandas Rao KG, Smita Shenoy, Rajashekar Chinta, Chetan Hasmukh Mehta, Usha Yogendra Nayak. Sphingosine-1-Phosphate Receptor Modulator – Siponimod: An Evaluation to Ameliorate Aluminium Chloride Induced Behavioural Change and Biochemical effects. 亚洲通_亚洲通官网 Journal of Pharmacy and Technology. 2024; 17(1):179-7.
4.?Kumar S,?Chhabra V,?Mehra M,Saranya K, Kumar BH, Shenoy S, Swamy RS,?Pai KM, Pai KSR,?Kumar N.?The fluorosis conundrum: bridging the gap between science and public health. Toxicology Mechanisms and Methods?2024; 34(2): 214–35.
5.?Kumar, S.,?Chhabra, V.,?Shenoy, S.,?Daksh R, Ravichandiran V, Swamy, R.S.,?Kumar, N. Role of Flavonoids in Modulation of Mitochondria Dynamics during Oxidative Stress. Mini-Reviews in Medicinal Chemistry.?2024; 24(9): 908–19.
1. The effect of ketamine on behaviors of Drosophila melanogaster with depression-like state.
2. Off label prescribing in cancer patients
3. Drug – drug interactions in palliative care
4. Sirtuins in fluoride induced toxicity